Steve Horvath

Steve Horvath, a biogerontologist who created methylation clocks like GrimAge, breaks down biological age and what it measures. He discusses how methylation clocks work, why lifestyle factors like vegetables and walking matter, the limits and risks of consumer tests, centenarian insights, and where AI and drugs might take aging research next.

Steve Horvath, a expert in methylation, epigenetics, and longevity, discusses the overlooked role of epigenetics in health and lifespan, using methylation patterns to predict lifespan, and the significance of GrimAge for reducing early mortality. The podcast explores genetics, moderate lifestyle choices, and the Horvath aging clock's importance in longevity research and biohacking communities.

Steve Horvath, Mathematiker und Erfinder der epigenetischen Uhr, erklärt seine Motivation, das biologische Alter messbar zu machen. Gespräche behandeln die epigenetische Uhr, Laborarbeit zur Zellverjüngung und den Yamanaka-Cocktail. Es geht um Teilreprogrammierung, Tierstudien, erste Menschenversuche und ethische Grenzen der Verjüngungsforschung.

Dr. Steve Horvath is a renowned aging researcher and geneticist at UCLA, famous for his epigenetic aging clocks. In this conversation, he unpacks the concept of epigenetic clocks and their role in predicting mortality, emphasizing the impressive accuracy of his GrimAge model. Horvath also reveals groundbreaking advances like the Universal Mammalian Clock and discusses how young plasma studies show potential for significant rejuvenation. He highlights the modest impact of lifestyle changes on epigenetic age and the need for more biomarker-based clinical trials.

Join Steve Horvath, a renowned geneticist and inventor of the Horvath Clock, as he discusses groundbreaking advances in epigenetics. He explores how DNA methylation can predict biological age and health risks. Discover the complexities of measuring aging and how unique methylation landscapes in long-lived species reveal new insights. Steve also touches on exciting anti-aging research at Altos Labs and the potential of GLP-1 drugs to revolutionize aging interventions. It's a fascinating glimpse into the future of age-related health!